| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/12/2009 | CN100525774C DiAo Xinxuekang soft capsule and preparation process and use thereof |
| 08/12/2009 | CN100525773C Injectable azithromycin freeze-dried powder, and its preparation method |
| 08/12/2009 | CN100525772C Application of 20(S)-panaxcoside -Rg3 in preparation of medicine for treating or preventing high blood pressure |
| 08/12/2009 | CN100525771C Medicine possessing menacme accerant contraception action |
| 08/12/2009 | CN100525770C Oral compound slow-released pharmaceutics containing theine and salmol active constituent and preparation process thereof |
| 08/12/2009 | CN100525769C Sustained release formulation of raltitrexed and preparation method thereof |
| 08/12/2009 | CN100525767C Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein |
| 08/12/2009 | CN100525765C Lappaconitine hydrobromide dispersible tablet and its preparing method |
| 08/12/2009 | CN100525763C Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 08/12/2009 | CN100525760C Duloxetine hydrochloride sustained release medicine |
| 08/12/2009 | CN100525759C Ready-made medicine of traditional chinese medicine for treating ischemic cranial vascular disease |
| 08/12/2009 | CN100525758C Garcinolic acid liposome and freezing-drying powdery preparation and its making method |
| 08/12/2009 | CN100525756C Coated ubenimex table |
| 08/12/2009 | CN100525755C Coated tablets |
| 08/12/2009 | CN100525753C Submicron emulsion injection liquid of CoQ10 and preparation process thereof |
| 08/12/2009 | CN100525752C Production of release-controlled film in percutaneous medicine-feeding system |
| 08/12/2009 | CN100525751C Meridian point therapeutic plaster of high polymer multi hole energy gathering ion and its preparation method and application |
| 08/12/2009 | CN100525750C Toxin-expelling face-nourishing soft capsules and preparing method |
| 08/12/2009 | CN100525749C Freeze-drying powder injection for treating calor febrilis and its production |
| 08/12/2009 | CN100525748C New preparation of medicine, its preparation and application method |
| 08/12/2009 | CN100525747C Process for preparing Tibetan medicine soup promoting medicine composition |
| 08/11/2009 | US7572833 E.g., N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal stabilized with a lipid; improved absorption and penetration; treating ischemia, immune diseases, Alzheimer's disease, osteoporosis, brain disorders, eye diseases, osteoporosis |
| 08/11/2009 | US7572828 Identification of anti-HIV compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid |
| 08/11/2009 | US7572791 Long-term stability, extended delivery using a suitable reservoir; pumped or metered at a controlled rate; implantable or external pump device, pen style injection device; stable at physiologic temperatures for duration of therapeutic exposure; supply of therapeutically active material for up to 2 years |
| 08/11/2009 | US7572782 Use of targeted oxidative therapeutic formulation in bone regeneration |
| 08/11/2009 | US7572779 Improved oral bioavailability of 17 beta-estradiol by adminstering the lower alkanoate; contraceptives, hormone replacement therapy |
| 08/11/2009 | US7572773 Single dose fast dissolving azithromycin |
| 08/11/2009 | US7572613 Drug delivery system for accelerated subcutaneous absorption |
| 08/11/2009 | US7572463 Oral dosage forms |
| 08/11/2009 | US7572458 Boron compound-layered double hydroxide nanohybrid, method of preparing the boron compound-LDH nanohybrid, and pharmaceutical composition comprising the boron compound-LDH nanohybrid |
| 08/11/2009 | US7572397 Microcapsules |
| 08/11/2009 | US7572245 Application of a therapeutic substance to a tissue location using an expandable medical device |
| 08/11/2009 | CA2548834C Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same |
| 08/11/2009 | CA2476520C Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound |
| 08/11/2009 | CA2470581C Antidiabetic formulation and method |
| 08/11/2009 | CA2448825C Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/11/2009 | CA2447614C A method of implanting heavy metal such as nobel metal, e.g. gold, and metal for use in implantation |
| 08/11/2009 | CA2417089C Palatable oral coenzyme q liquid |
| 08/11/2009 | CA2399344C Medical adhesive composition and adhesive tape or sheet using the composition |
| 08/11/2009 | CA2397447C Reduced form of coenzyme q in high bioavailability stable dosage forms and related applications |
| 08/11/2009 | CA2392013C Analgesic compositions containing buprenorphine in combination with naloxone, naltrexone or nalmefene |
| 08/11/2009 | CA2382013C Pharmaceutical solutions of levosimendan |
| 08/11/2009 | CA2359699C Biodegradable ceramic fibres from silica sols |
| 08/11/2009 | CA2358361C Stable compositions for parenteral administration and their use |
| 08/11/2009 | CA2336432C Monolayer sugar-coated tablet and process for preparation thereof |
| 08/11/2009 | CA2315890C Rate controlling membranes for controlled drug delivery devices |
| 08/11/2009 | CA2198390C Matrix for transdermal drug delivery |
| 08/08/2009 | CA2653300A1 Polyvalent vaccine against salmonid alphavirus infections |
| 08/06/2009 | WO2009097570A2 Intralymphatic chemotherapy drug carriers |
| 08/06/2009 | WO2009097561A1 Wound closing compounds with additives |
| 08/06/2009 | WO2009097508A2 Methods and compositions for wound healing |
| 08/06/2009 | WO2009097443A2 Liquid formulations of compounds active at sulfonylurea receptors |
| 08/06/2009 | WO2009097439A1 Nano-devices having valves for controlled release of molecules |
| 08/06/2009 | WO2009097349A1 Therapeutic compositions |
| 08/06/2009 | WO2009097332A2 Therapeutic compositions comprising an amine-containing lipid and a protein |
| 08/06/2009 | WO2009097156A1 Pharmaceutical capsules comprising extended release dipyridamole pellets |
| 08/06/2009 | WO2009097011A1 Improved platinum drug formulations |
| 08/06/2009 | WO2009096985A1 Sustained release particulate oral dosage forms of (r)-baclofen prodrugs and methods of treatment |
| 08/06/2009 | WO2009096908A2 Extended-release fluvastatin tablet |
| 08/06/2009 | WO2009096822A1 Drug delivery devices and methods and applications thereof |
| 08/06/2009 | WO2009096579A1 Nutritional composition for prevention of hyperglycemia |
| 08/06/2009 | WO2009096560A1 Orally rapidly disintegrating tablet comprising imidafenacin |
| 08/06/2009 | WO2009096559A1 Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient |
| 08/06/2009 | WO2009096487A1 Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation |
| 08/06/2009 | WO2009096354A1 Fentanyl-containing patch for external use |
| 08/06/2009 | WO2009096315A1 Adhesive patch |
| 08/06/2009 | WO2009095934A1 Modified release formulations of hmg coa reductase inhibitors |
| 08/06/2009 | WO2009095684A1 Pulmonary formulations of triptans |
| 08/06/2009 | WO2009095681A2 Suspension formulations |
| 08/06/2009 | WO2009095670A1 Soft gel capsules |
| 08/06/2009 | WO2009095621A1 Galenic form for the oral transmucosal delivery of triptans |
| 08/06/2009 | WO2009095591A1 Method for making patches by electrospray |
| 08/06/2009 | WO2009095560A1 Pharmaceutical compositions containing azetidine derivatives |
| 08/06/2009 | WO2009095485A1 Pharmaceutical composition with gelling properties containing a tyrosine derivative |
| 08/06/2009 | WO2009095450A1 Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers |
| 08/06/2009 | WO2009095448A1 Preparation of nanoparticles by using a vibrating nozzle device |
| 08/06/2009 | WO2009095423A2 Oral care composition for combating dentine hypersensitivity |
| 08/06/2009 | WO2009095395A2 Pharmaceutical compositions |
| 08/06/2009 | WO2009095223A1 Injectable biocompatible composition |
| 08/06/2009 | WO2009095210A1 Composition comprising an antacid and a h2-antagonists |
| 08/06/2009 | WO2009095151A1 Micro- and/or nano-structured packaging material |
| 08/06/2009 | WO2009095057A2 Transdermal therapeutic system having urea components |
| 08/06/2009 | WO2009094846A1 Insulin nasal powder inhalation |
| 08/06/2009 | WO2009094811A1 A royal jelly acidic mixture preparation and application thereof |
| 08/06/2009 | WO2009094798A1 A pharmaceutical product for filterable viral infection and processing method thereof |
| 08/06/2009 | WO2009094750A1 Fast dissolution amino acid composition |
| 08/06/2009 | WO2009074853A3 Ophthalmic composition comprising phenylephrine |
| 08/06/2009 | WO2009074811A3 Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis |
| 08/06/2009 | WO2009069991A3 Cellular therapeutic agent for incontinence of urine comprising stem cells originated from decidua or adipose |
| 08/06/2009 | WO2009067046A3 Method for producing polymer coating on particle surfaces |
| 08/06/2009 | WO2009059120A3 Injectable meclizine formulations and methods |
| 08/06/2009 | WO2009056266A3 Candesartan cilexetil |
| 08/06/2009 | WO2009052353A3 Trospium pharmaceutical formulations |
| 08/06/2009 | WO2009040702A3 Pharmaceutical compositions of rhein or diacerein |
| 08/06/2009 | WO2009029958A4 Implantable delivery device |
| 08/06/2009 | WO2009009563A3 Materials and methods for delivering compositions to selected tissues |
| 08/06/2009 | WO2009008006A3 Pharmaceutical compositions for gastrointestinal drug delivery |
| 08/06/2009 | WO2009007764A3 Pharmaceutical preparations containing highly volatile silicones |
| 08/06/2009 | WO2008149238A3 Formulation of meningitis vaccines |
| 08/06/2009 | WO2008125940A3 Nanoparticles comprising non-crystalline drug |